Month: February 2020
President Donald Trump in his State of the Union address on Tuesday called on lawmakers to pass legislation to lower prescription drug prices and derided single-payer healthcare reform as "socialist."
Governors of both major political parties are warning that a little-noticed regulation proposed by President Donald Trump's administration could lead to big cuts in Medicaid, reducing access to health care for low-income Americans.
Writing in payment limits when signing hospital forms might provide some leverage over disputes that arise from surprise medical bills, some proponents suggest.
Four military bases in Texas, California and Colorado were preparing to house American citizens for up to two weeks as part of a highly unusual federal effort aimed at slowing the spread of the deadly coronavirus. As of late Monday, though, expectations that a large number of Americans who had traveled to parts of China might quickly be held under quarantine had not come to pass.
The federal government on Friday proposed changes to standards governing ACA-compliant health plans sold on the exchanges in 2021, several of which aim to ensure the CMS doesn't provide subsidies to ineligible people.
The federal government notified Gov. Gavin Newsom’s administration Friday that it is rejecting California’s Medicaid financing proposal, a decision that could cost the state $1.2 billion.
With the first votes of the 2020 Democratic presidential primary season approaching, large majorities of Democrats – and most of the public overall – support both of the major approaches primary candidates have put forward to expand coverage and make health care more affordable, though a public option remains significantly more popular than Medicare-for-all, the latest KFF Health Tracking Poll finds.
The Trump administration and Republican-led states told the Supreme Court on Monday that it should not step in at this time to consider the fate of the Affordable Care Act.
CVS Health Corp. will drop three directors from its 16-member board, including Mark Bertolini, the former chief executive of Aetna, the health insurer it bought in a transformative $68 billion deal in 2018.
Insurers charge that the Trump administration’s price transparency rule will cost 26 times more than estimated, and the amount of data they must disclose is “staggering.”